Frost Berry
A berry-scented hybrid with limited public data, sold mostly as a boutique cross with disputed and poorly documented parentage.
Frost Berry is one of many berry-named hybrids floating around dispensary menus with almost no verifiable provenance. Multiple breeders have used the name for unrelated crosses, and there is no stable, publicly documented genetic lineage. Chemistry ranges reported by labs are typical mid-shelf hybrid numbers, not anything unusual. Treat any strain-specific effect claims — including on this page — as anecdote. If you like it, buy it again from the same grower; the name alone tells you very little.
Overview
Frost Berry is a boutique hybrid name that has appeared on dispensary menus in North America, primarily in California, Oregon, and Michigan markets, since roughly the late 2010s. There is no single breeder of record, no seedbank release that clearly established the name, and no widely accepted phenotype description. Vendor descriptions usually emphasize a sweet berry aroma, visible trichome coverage (the 'frost'), and a relaxing body-forward effect Anecdote.
Because cannabis strain names are not trademarked or regulated in most jurisdictions, different growers can sell genetically unrelated plants under the same name. Independent genetic testing efforts such as Phylos Bioscience have repeatedly shown that same-named cannabis samples often cluster into multiple distinct genetic groups [1]. Frost Berry should be assumed to be one of these ambiguous names unless a specific grower can document their seed source.
Chemistry
No peer-reviewed chemotype study has profiled a plant sold under the name Frost Berry. Publicly available state lab data (e.g. Leafly and Weedmaps aggregations of COAs) suggests total THC in the high teens to low twenties percent by dry weight, with negligible CBD — a profile consistent with the vast majority of modern commercial hybrids Weak / limited.
Reported dominant terpenes vary batch to batch. Some COAs list myrcene as the top terpene; others list beta-caryophyllene or limonene. This inconsistency is normal for a name without a locked genetic source. The popular idea that a specific terpene percentage (such as the often-cited 'myrcene above 0.5% makes it an indica') predicts sedation is folklore, not established pharmacology [2][3]. Terpene levels influence aroma reliably; their effect on subjective experience at inhaled cannabis doses is not well established Disputed.
Reported effects
Users on public review sites describe Frost Berry as relaxing, mildly euphoric, and appetite-stimulating, with common reports of dry mouth and dry eyes Anecdote. These are the same effects reported for essentially every THC-dominant flower and should not be read as strain-specific pharmacology.
There are no clinical trials of Frost Berry or any similarly named cultivar. Systematic reviews of cannabis effects generally find that dose, THC:CBD ratio, route of administration, and individual tolerance predict subjective effects far more reliably than strain name or indica/sativa labeling [4][5]. The indica/sativa binary in particular has been shown to not map onto either chemistry or effects in a consistent way [6] Strong evidence.
Lineage
Lineage for Frost Berry is disputed and unverified. Common vendor claims include:
- A cross of Blueberry × The White (or Wedding Cake in some listings)
- A Blackberry Kush phenotype selection
- An unrelated Frostbite × Berry pairing
None of these claims are backed by a documented breeder release, seedbank catalog entry, or genetic assay in the public record No data. Cannabis pedigree databases such as SeedFinder list the name with placeholder or user-submitted parentage rather than breeder-confirmed genetics [7].
Until a breeder publishes verifiable records — ideally with a genetic marker panel — any lineage statement about Frost Berry should be read as marketing copy.
Cultivation basics
Because there is no locked genetic source, cultivation notes here are generic to the phenotypes commonly sold under the name.
- Flowering time: Reported 56–65 days indoors Anecdote.
- Structure: Growers describe medium-height, moderately branchy plants that respond to topping and low-stress training.
- Yield: No verified figures; vendor claims of 'high yield' are not substantiated.
- Environment: Like most modern hybrids, prefers 20–26°C, moderate humidity dropping in late flower to reduce bud rot risk on dense colas.
- Feeding: Standard hybrid schedules; no documented nutrient sensitivities.
If you are buying seeds or clones labeled Frost Berry, ask the source for a photo record and, ideally, a chemotype report from a previous run. That is more informative than the name.
Marketing vs. reality
Marketing claim: 'Frost Berry is an indica-dominant hybrid that delivers deep relaxation thanks to its high myrcene content.'
Reality: The indica/sativa label does not reliably predict effects [6]. Myrcene's role as a sedative in inhaled cannabis is not established in controlled human studies — the widely repeated '0.5% myrcene threshold' has no published pharmacological basis and appears to originate from a 1997 book passage that has been repeated without primary evidence [3] Disputed.
Marketing claim: 'A rare cross of elite genetics.'
Reality: No breeder has publicly documented the cross. 'Rare' and 'elite' are unregulated adjectives in cannabis retail.
What actually matters when buying it: the specific grower, a recent certificate of analysis (COA) with cannabinoid and terpene numbers, harvest date, and storage. Those tell you far more about what you're smoking than the name Frost Berry does.
Sources
- Peer-reviewed Sawler J, Stout JM, Gardner KM, et al. (2015). The genetic structure of marijuana and hemp. PLOS ONE, 10(8): e0133292.
- Peer-reviewed Russo EB (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7): 1344–1364.
- Peer-reviewed Cogan PS (2020). The 'entourage effect' or 'hodge-podge hashish': the questionable rebranding, marketing, and expectations of cannabis polypharmacy. Expert Review of Clinical Pharmacology, 13(8): 835–845.
- Peer-reviewed MacCallum CA, Russo EB (2018). Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine, 49: 12–19.
- Peer-reviewed Kruger DJ, Kruger JS (2022). Consumer experiences with cannabis flower and concentrates. Journal of Cannabis Research, 4: 43.
- Peer-reviewed Watts S, McElroy M, Migicovsky Z, et al. (2021). Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 7: 1330–1334.
- Reported SeedFinder strain database entry conventions and user-submitted lineage disclaimers.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...